Greenberg R - Search Results

1

Harnessing choice architecture in urologic practice: Implementation of an opioid-sparing protocol grounded in cognitive behavioral theory.

Bernstein AN, Nourian A, Strother M, Lobo A, Devarajan K, Richman D, Hill MV, Conrad L, Magagna A, Viterbo R, Greenberg R, Chen D, Smaldone M, Correa A, Uzzo R, Kutikov A. Bernstein AN, et al. Among authors: greenberg r. Urol Oncol. 2022 Mar;40(3):95-102. doi: 10.1016/j.urolonc.2021.10.011. Epub 2021 Dec 6. Urol Oncol. 2022. PMID: 34876350

2

Decision-making strategies for patients with localized prostate cancer.

Diefenbach MA, Dorsey J, Uzzo RG, Hanks GE, Greenberg RE, Horwitz E, Newton F, Engstrom PF. Diefenbach MA, et al. Semin Urol Oncol. 2002 Feb;20(1):55-62. doi: 10.1053/suro.2002.30399. Semin Urol Oncol. 2002. PMID: 11828358

3

Free prostate-specific antigen improves prostate cancer detection in a high-risk population of men with a normal total PSA and digitalrectal examination.

Uzzo RG, Pinover WH, Horwitz EM, Parlanti A, Mazzoni S, Raysor S, Mirchandani I, Greenberg RE, Pollack A, Hanks GE, Watkins-Bruner D. Uzzo RG, et al. Urology. 2003 Apr;61(4):754-9. doi: 10.1016/s0090-4295(02)02524-4. Urology. 2003. PMID: 12670560

4

Modifying the American Society for Therapeutic Radiology and Oncology definition of biochemical failure to minimize the influence of backdating in patients with prostate cancer treated with 3-dimensional conformal radiation therapy alone.

Horwitz EM, Uzzo RG, Hanlon AL, Greenberg RE, Hanks GE, Pollack A. Horwitz EM, et al. J Urol. 2003 Jun;169(6):2153-7; discussion 2157-9. doi: 10.1097/01.ju.0000067181.52741.09. J Urol. 2003. PMID: 12771738

5

Clinical, demographic and psychosocial correlates of complementary and alternative medicine use by men diagnosed with localized prostate cancer.

Diefenbach MA, Hamrick N, Uzzo R, Pollack A, Horwitz E, Greenberg R, Engstrom PF. Diefenbach MA, et al. Among authors: greenberg r. J Urol. 2003 Jul;170(1):166-9. doi: 10.1097/01.ju.0000070963.12496.cc. J Urol. 2003. PMID: 12796672

6

The basic biology and immunobiology of renal cell carcinoma: considerations for the clinician.

Uzzo RG, Cairns P, Al-Saleem T, Hudes G, Haas N, Greenberg RE, Kolenko V. Uzzo RG, et al. Urol Clin North Am. 2003 Aug;30(3):423-36. doi: 10.1016/s0094-0143(03)00021-1. Urol Clin North Am. 2003. PMID: 12953746 Review.

7

Promoter hypermethylation of tumor suppressor genes in urine from kidney cancer patients.

Battagli C, Uzzo RG, Dulaimi E, Ibanez de Caceres I, Krassenstein R, Al-Saleem T, Greenberg RE, Cairns P. Battagli C, et al. Among authors: greenberg re. Cancer Res. 2003 Dec 15;63(24):8695-9. Cancer Res. 2003. PMID: 14695183

8

Detection of bladder cancer in urine by a tumor suppressor gene hypermethylation panel.

Dulaimi E, Uzzo RG, Greenberg RE, Al-Saleem T, Cairns P. Dulaimi E, et al. Clin Cancer Res. 2004 Mar 15;10(6):1887-93. doi: 10.1158/1078-0432.ccr-03-0127. Clin Cancer Res. 2004. PMID: 15041703

9

Cutaneous metastases from genitourinary malignancies.

Mueller TJ, Wu H, Greenberg RE, Hudes G, Topham N, Lessin SR, Uzzo RG. Mueller TJ, et al. Among authors: greenberg re. Urology. 2004 Jun;63(6):1021-6. doi: 10.1016/j.urology.2004.01.014. Urology. 2004. PMID: 15183939 Review.

10

Promoter hypermethylation profile of kidney cancer.

Dulaimi E, Ibanez de Caceres I, Uzzo RG, Al-Saleem T, Greenberg RE, Polascik TJ, Babb JS, Grizzle WE, Cairns P. Dulaimi E, et al. Clin Cancer Res. 2004 Jun 15;10(12 Pt 1):3972-9. doi: 10.1158/1078-0432.CCR-04-0175. Clin Cancer Res. 2004. PMID: 15217927

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,962 results

Search Page